HemeTalks: Conversations in Hematology Education
Health, Fitness & Longevity
About
HemeTalks: Conversations in Hematology Education is the latest podcast channel by the American Society of Hematology (ASH)! Explore educational content crafted by subject-matter experts from ASH, tailored to fulfill your professional education requirements. Whether you are a clinician or researcher, HemeTalks provides innovative education designed for every career stage and subspecialty.
Episodes
- TTP Today: Diagnosis, Management & Evolving Therapies
This HemeTalks episode covers TTP, a hematologic emergency. Drs. Yazan Abou-Ismail and Kolton Smith discuss diagnosis, management, and therapies, including caplacizumab and ADAMTS13 testing, using a clinical case to illustrate key points.
- Approaching MDS: Advances in Diagnostics, Therapeutics and Monitoring
Drs. DeZern and Mack review the diagnosis, therapeutics, and monitoring of myelodysplastic neoplasms (MDS), discussing molecular diagnostics, risk assessment, and treatment options for lower and higher-risk disease.
- New Horizons in Smoldering Multiple Myeloma
Professors Brea Lipe and Sagar Lonial discuss the evolving treatment of smoldering multiple myeloma (SMM), covering diagnosis, risk stratification, and management, including a case study and early intervention trial data.
- Interpreting Abnormal SPEP – Is It Just MGUS?
Drs. Rahma Warsame and Jason Chen discuss interpreting abnormal SPEP results and evaluating patients with suspected MGUS on HemeTalks. They cover differentiating benign from concerning findings using real-world cases, outlining clinical de…
- Sticky Situations: The Role of Thrombophilia Testing in VTE Management
This episode explores the debate around thrombophilia testing in VTE management. Drs. Mistry and May discuss interpreting test results, identifying appropriate clinical situations, and how testing influences anticoagulation duration decisi…
- Lost in Translation: The aHUS Experience
This HemeTalks episode discusses the challenges of diagnosing and managing atypical hemolytic uremic syndrome (aHUS), featuring insights from a patient advocate and a physician. It emphasizes the importance of patient advocacy, community s…
- Inclusion of those with those with Duffy-null Associated Neutrophil Count (DANC) in Clinical Trials
This episode of HemeTalks discusses the Duffy null phenotype, its effect on neutrophil counts, and the resulting disparities in clinical trials. It covers recommendations for inclusive trial design and equitable patient care, highlighting…
- Thalassemia in Pediatric Hematology
This episode of HemeTalks features Drs. Sujit Sheth and Ashutosh Lal discussing thalassemia in pediatric hematology. They cover its global prevalence, types, diagnostic strategies, current treatments like transfusion and chelation, and eme…
- Bridging the Gap: Coordinating CAR-T Care Between Community and Academic Practices
This HemeTalks episode discusses coordinating CAR-T therapy between academic and community practices, using a patient case to explore logistics, toxicity management, and patient support. It emphasizes clear communication, shared responsibi…
- Relapsed Myeloma: Navigating Post-BCMA Therapy Failure
This episode of HemeTalks features Drs. Natalia Neparidze and Saad Z. Usmani discussing treatment strategies for relapsed multiple myeloma following BCMA-targeted therapy failure. They cover resistance mechanisms, treatment sequencing, and…
- Hereditary Hemorrhagic Telangiectasia: Diagnosis, Management, and Advances
This episode of HemeTalks features Drs. Hanny Al-Samkari and Adrienne Hammill discussing hereditary hemorrhagic telangiectasia (HHT). They cover its diagnosis, management challenges, clinical features, diagnostic criteria, imaging, genetic…
- Thrombotic Microangiopathy in Pregnancy: Challenges and Advances
This HemeTalks episode discusses thrombotic microangiopathy (TMA) in pregnancy, differentiating it from preeclampsia and HELLP syndrome. It covers diagnostic approaches and management strategies, including delivery and plasma exchange, to…
- Unveiling Von Willebrand Disease: Advances in Diagnosis and Treatment
This episode of HemeTalks features Dr. Jill Johnsen and Dr. Michelle Sholzberg discussing Von Willebrand Disease (VWD), the most common inherited bleeding disorder. They cover its pathophysiology, diagnostic challenges, and recent treatmen…
- Battling Invisible Enemies: Toxic Exposures and Hematologic Cancers in Military Members
This HemeTalks episode discusses the link between military toxic exposures and hematologic cancers like leukemia, lymphoma, and myeloma. Hosts Dr. Christin DeStefano and Dr. Drew Helmer cover diagnostic and treatment challenges, research p…
- Iron-Clad Health: Tackling Iron Deficiency in Women
Drs. Anjlee Mahajan, Angela Weyand, and Michelle Sholzberg discuss how current standards of care can lead to disparities in diagnosing and treating iron deficiency, especially in women. The episode offers insights into overcoming these cha…
- The Road to Inclusion: Navigating Challenges to Haploidentical Donor Transplants
Drs. Shakira Grant and Irum Kahn discuss the evolution of haploidentical stem cell transplants, highlighting their impact on patient care and the critical need for diversity in donor registries. The episode also addresses patient barriers…
- Blood for All: Clinical Impacts of Diverse Donor Pools
Dr. Rahma Warsame and Dr. Margo Rollins discuss the clinical significance of diverse blood donors, the challenges in recruiting and retaining donors from BIPOC communities, and strategies to improve donor diversity for better patient outco…
- Advancing Sickle Cell Disease Care: A conversation between cellular therapy & BMT providers
This episode features cellular therapy and BMT providers discussing advancements in sickle cell disease care, covering curative therapies, gene editing, and BMT. They also address challenges in integrating these treatments and strategies t…
- Inside ASH 2024: Insights from the Education Program Co-Chairs
This HemeTalks episode features the Co-Chairs of the 2024 ASH Annual Meeting Education Program, discussing the planning process, strategic goals, and challenges overcome. The discussion highlights how the program aims to meet the diverse n…
- Blood Transfusion Safety: TRALI vs TACO
This HemeTalks episode discusses blood transfusion safety, focusing on TRALI and TACO. It covers their pathophysiology, clinical presentation, diagnostic criteria, and management strategies for hematologists.
- Advancing Sickle Cell Disease Care: Navigating Gene Therapy
This HemeTalks episode focuses on gene therapy for sickle cell disease (SCD), explaining basic principles and comparing it to other treatments. It provides guidance for hematologists and generalist providers on counseling patients and fami…
- Updates in Thalassemia: New Challenges and Novel Treatment Approaches
This HemeTalks episode discusses the evolving challenges and novel treatment strategies for thalassemia, covering diagnostic approaches from newborn screening to older adults, current management practices like transfusions and monitoring,…
- Multiple Myeloma in Underrepresented Populations: Treatment Considerations
HemeTalks features Drs. Azam Farooqui and Monique Hartley-Brown discussing therapeutic approaches for multiple myeloma patients from underrepresented racial and ethnic groups. An upcoming IMPACT II module on ASH Academy On Demand will focu…
- Multiple Myeloma in Underrepresented Populations: Survival Outcomes
Drs. Azam Farooqui and Sikander Ailawadhi discuss the importance of early diagnosis and intervention for multiple myeloma patients in underrepresented populations, addressing factors influencing survival outcomes.
- Multiple Myeloma in Underrepresented Populations: Clinical Risk
Drs. Azam Farooqui and Urvi Shah discuss factors influencing outcomes for patients with multiple myeloma from underrepresented racial and ethnic groups. An online learning module on this topic will be available on ASH Academy On Demand.
- IMPACT II: Impacting Multiple Myeloma in All CommuniTies
This HemeTalks series, IMPACT II, focuses on multiple myeloma treatment in underrepresented racial and ethnic populations. Episodes feature experts discussing factors influencing outcomes, survival differences, and therapeutic consideratio…
- GENOM: Myelodysplastic Syndromes and Clonal Hematopoiesis
Drs. Michael Diaz and Namrata Chandhok discuss the role of genomic testing in understanding and treating myelodysplastic syndromes and clonal hematopoiesis, including interpreting results and selecting therapies. This episode is a collabor…
- GENOM: Acute Myeloid Leukemia
Drs. Michael Diaz and James Blachly discuss the significance of genomic testing and interpreting results for acute myeloid leukemia (AML). They also cover selecting appropriate therapies for hematologic malignancies. This episode is a coll…
- GENOM: Acute Lymphoblastic Leukemia
Drs. Michael Diaz and Emily K. Curran discuss the role of genomic testing in treating acute lymphoblastic leukemia, including understanding results and selecting therapies. This episode is a collaboration between the American Society of He…
- GENOM: Myeloma
Drs. Sanjay Juneja and Ajai Chari discuss the importance of genomic testing and interpreting results for myeloma patients. They also cover selecting appropriate therapies for hematologic malignancies. This episode is a collaboration betwee…
- GENOM: Lymphoma
Drs. Sanjay Juneja and David Russler-Germain discuss the significance of genomic testing and interpreting results for lymphoma patients. They also cover selecting appropriate therapeutic agents for hematologic malignancies. This episode is…
- GENOM: Chronic Lymphocytic Leukemia
Drs. Juneja and Barrientos review the significance of genomic testing in Chronic Lymphocytic Leukemia (CLL) treatment. They cover understanding test results and choosing therapies for hematologic malignancies, in collaboration with the Ame…
- HemeTalks, a podcast featuring conversations in hematology education.
HemeTalks is a new podcast from the American Society of Hematology (ASH) offering educational content for hematology professionals. Season 1 will focus on the role of genomics in hematologic malignancies, featuring experts from academic an…